chronic kidney disease

Endocrinology

Endocrinology Today—May 26, 2026

This week’s Endocrinology update highlights regulatory progress, reimbursement…

by LucidQuest

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: R1 Therapeutics $77.5 million Series A to treat hyperphosphatemia in CKD dialysis

Lucid Diligence Brief: R1 Therapeutics $77.5 million Series A to treat…

by Timos Papagatsias

Lucid Diligence Brief - BioPharma

Lucid Diligence Brief: Rectify and Boehringer Ingelheim partnership in CKD

Lucid Diligence Brief: Rectify and Boehringer Ingelheim partnership in CKD…

by Timos Papagatsias

Cardiovascular

Cardiovascular Video Recap—November 20, 2025

This Cardiovascular Video Recap covers regulatory approvals, large real-world…

by LucidQuest

Privacy Preference Center

Privacy Preferences

When you visit any website, it may store or retrieve information on your browser in the form of cookies. Since we respect your right to privacy, you can choose not to permit data collection from certain types of services. However, not allowing these services may impact your experience ans we are able to offer you.

Privacy Policy

Required
You read and agreed to our Privacy Policy

Tracking

We use third-party cookies that help us analyze and understand how you use this website. These cookies do not store any personal information.